دورية أكاديمية

Promoter Hypermethylation and Underexpression of Patched Homolog 1 in Pancreatic and Colorectal Cancers: A Cross-Sectional Study.

التفاصيل البيبلوغرافية
العنوان: Promoter Hypermethylation and Underexpression of Patched Homolog 1 in Pancreatic and Colorectal Cancers: A Cross-Sectional Study.
المؤلفون: NIYAZ, Madiha, KHAN, Mosin Saleem, SHAH, Aaliya, WANI, Rauf Ahmad, SHAH, Omar Javid, BESINA, Syed, MUDASSAR, Syed
المصدر: Turkish Journal of Oncology / Türk Onkoloji Dergisi; 2021, Vol. 36 Issue 4, p478-488, 11p
مصطلحات موضوعية: PANCREATIC tumors, CELL culture, DNA, CONFIDENCE intervals, CROSS-sectional method, WESTERN immunoblotting, COLORECTAL cancer, GENE expression, CELLULAR signal transduction, METHYLATION, DESCRIPTIVE statistics, MEMBRANE proteins, POLYMERASE chain reaction, DATA analysis software, ODDS ratio
مستخلص: OBJECTIVE Patched homolog 1 (PTCH1) - a trans-membrane protein is a tumor suppressor which negatively regulates Hedgehog signaling pathway. The present study aimed to investigate the promoter hypermethylation and protein expression pattern of PTCH1 in Pancreatic cancer (PC) and Colorectal cancer (CRC). METHODS Promoter hypermethylation of PTCH1 gene was analyzed using Methylation-Specific Polymerase Chain Reaction and protein expression pattern was studied using western blotting. RESULTS Promoter hypermethylation of the PTCH1 gene was found in 42.42% (14/33) and 55.73% (34/61) of Pancreatic and Colorectal tumor samples, respectively. A significant correlation was found between PTCH1 hypermethylation and smoking status in PC while PTCH1 hypermethylation in CRC was significantly correlated with late-stage disease and lymph node metastasis. PTCH1 protein was under expressed in 30.3% (10/33) and 50.8 % (31/61) of Pancreatic and Colorectal tumor samples, respectively. Methylation analysis of PTCH1 in Pancreatic adenocarcinoma cell line 1 (PANC-1) and Colorectal adenocarcinoma cell line (HT-29) revealed hemi methylation in PANC-1, complete methylation in HT-29 and methylation was clearly associated with loss of expression. CONCLUSION Our results indicate that epigenetic silencing of the PTCH1 promoter and concomitant loss of PTCH1 protein expression may play an important role in the development and progression of these cancers. [ABSTRACT FROM AUTHOR]
Copyright of Turkish Journal of Oncology / Türk Onkoloji Dergisi is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:13007467
DOI:10.5505/tjo.2021.2890